ICMS Medical Advisory Board

The Medical Advisory Board (MAB) is a vital  and important voice in the clinical translation of cell-based therapies. and a critical element in the ICMS mission to protect patients through strict evaluation and rigorous oversight of cell-based therapy providers.

The mission of the MAB is to:

Provide an initial evaluation of applications for Accreditation

Review and evaluate reported Severe Adverse Events

Provbide final recommednation to  grant or deny ICMS approval of accreditation


The members of the ICMS MAB are:


Toshio Miki, MD, PhD - Chair of the ICMS MAB
Assistant Professor of Research, Department of Biochemistry and Molecular Biology,
Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research
Keck School of Medicine - University of Southern California                                                                                                                                                             

borisBoris Minev, MD
Research Scientist, Cancer Center
University of California at San Diego
Chief Scientist, Triad Immunologies


amitAmit Patel, MD
Associate Professor of Surgery                                                                                                                                                        Division of Cardiothoracic Surgery
University of Utah


AntoninAntonin Bukovsky, MD, PhD
Professor of the Department of Obstetrics and Gynecology
University of Tennessee
College of Medicine and Graduate School of Medicine


VaijayanteeVaijayantee Belle, MD
Senior Neurosurgery Consultant
Dept of Neurological Sciences,
The Aditya Birla Memorial Hospital, India


mikeMichael Murphy, MD
Assistant Professor of Surgery
Clinical Director “Signature” Vascular and Cardiac Center of Adult Stem Cell Therapy
Indiana University